Biotech comes with a great many positive externalities for society, and can be a big positive for portfolios right now. Just because tech and innovation took some big hits in last year’s selloff doesn’t mean that biotech can’t perform right now, or even in a possible looming downturn — and looking at biotech ETFs’ performance [...] The post Biotech ETFs’ Performance Deserves A Look appeared first on ETF Trends .